Wednesday, August 17, 2016

BRIEF-Cancer Genetics receives New York state approval for Focus::Myeloid NGS-based panel

* Received New York state approval for its Focus::Myeloid

NGS-based panel for Myeloid malignancies

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)